Document:

PAN ASIA MINING CORP.

--------------------------------------------------------------------------------

April 3, 2001

Mr. James Poe
Room 803
Tung Hip Commercial Bldg.
248 Voeuz Road
Hong Kong

Dear Sirs:

Re:     Pan ASIA MINING CORP. (the "Company")
        Loan

This  is to confirm our agreement pursuant to which James Poe has agreed to loan
the  Company an aggregate of 5,000,000 common shares, at a deemed price of $0.10
per  share,  for  one  year, plus interest at the rate of prime +5. It is agreed
that  such  shares  will be held in trust and sold privately to further fund the
701  Mine  development.

In consideration for this loan, the Company has agreed to issue, 1,000,000 fully
paid and non-assessable common shares of the Company, at a deemed price of $0.10
per share (the "Bonus Shares").

The issuance of Bonus Shares are subject to the approval of the Canadian Venture
Exchange  and further to the approval of the board of directors, and the Company
hereby  undertakes  to  use  its best efforts to obtain such approval as soon as
possible.

This  agreement  may be signed in as many Counterparts as may be necessary, each
of  which so signed shall be deemed to be an original (and each signed copy sent
by  electronic  facsimile  transmission  shall be deemed to be an original), and
such  counterparts  together  shall  constitute  one and the same instrument and
notwithstanding  the  date  of execution shall be deemed to bear the date as set
forth  above.

if the above accurately reflects our agreement, please indicate your acceptance
of these terms by executing this letter in the space provided and returning it
to the Company.

Yours truly,

PAN ASIA MINING CORP.
Per:

------------------------------
George LaForme, Director

                              Accepted and Agreed to this 3rd day of April, 2001

                              /s/  James Poe
                              ----------------------------
                              JAMES POE
--------------------------------------------------------------------------------
                  2656 FINCH HILL, WEST VANCOUVER, BC, V7S 3H1
     TELEPHONE: (604) 608-6686 TOLL FREE:1-888-323-8833 FAX: (604) 608-6687

<PAGE><PAGE>

                                                                    EXHIBIT 10.1

January 8, 1999

TO:       Jeff Jones, President and CEO, BIOLASE

FROM:     Keith G. Bateman

SUBJECT:  Offer of Employment

This letter hereby acknowledges the agreement between Jeffrey Jones, President
and CEO of BioLase and Keith G. Bateman. Following is a synopsis of the position
and compensation agreed upon:

Position/Title:           Vice President, Global Sales

Responsibility:           All sales of all products, global. Management of all
                          sales personnel.

Reports to:               CEO

Compensation:

Base Salary:              $110,000

Tiered Commission Rate    Total compensation including base salary, commissions
& Year End Bonus:         and year end bonus is approximately $200,000 at
                          quota. See the attached Tables A & B for the base
                          salary component, the commission rate component and
                          the year bonus component of the total compensation.
                          Sales goals, targets, year end bonus and stock
                          options will be based on all sales of all products
                          from January 1, 1999 through December 31, 1999.

Quota:                    Quota per plan is $*****. In the event the DermaLase
                          is not available for sales and shipment by August 1,
                          1999, quota will be reduced to $*****.

Stock Options:            50,000 incentive stock options at $2 1/8 to accrue
                          over the first six months of employment and an
                          additional 50,000 vested options at $2 1/8 if year
                          end sales quota is met (see Tables A & B for details).
                          It is the intention of BioLase to offer similar stock
                          options in the year 2000. These year 2000 options
                          will have similar performance stipulations.
---------------------
*   In accordance with Rule 24b-2 under the Securities and Exchange Act of
    1934, this confidential information has been omitted from this exhibit
    pursuant to a request for confidential treatment, and has been filed
    separately with the Securities and Exchange Commission.

                                   Page 1 of 4

<PAGE>

Start Date:               January 8, 1999

Terms of Employment:      Either party may terminate this agreement at will with
                          the following exceptions: in the event BioLase is
                          acquired or merged, the new entity has the option of
                          (1) offering Bateman a one year contract at the same
                          or a better compensation plan, or (2) paying Bateman a
                          severance pay for nine months equal to his previous
                          nine months total compensation including base salary,
                          commissions and bonuses.

Both parties agree that this preliminary agreement may be replaced with a
refined version so long as the basic terms defined herein remain intact.

/s/ KEITH G. BATEMAN
-------------------------------------------------------------------------
I agree to the above terms and conditions of employment
Keith G. Bateman/Date

/s/ JEFFREY W. JONES
-------------------------------------------------------------------------
I agree to the above terms and conditions of employment for Keith G. Bateman
Jeffrey W. Jones
President & CEO
BIOLASE TECHNOLOGY, INC.

                                  Page 2 of 4

<PAGE>

                     COMPENSATION PLAN FOR KEITH G. BATEMAN
                                 VP GLOBAL SALES

     Table A:
<TABLE>
<CAPTION>

----------------------------------------------------------------------------------------------------------------
          Monthly Sales Amount   Monthly Sales   Commission Rate    Monthly      Annualized Sales   Annualized
                                    Amount                         Commission        Amount         Commission
----------------------------------------------------------------------------------------------------------------
<S>     <C>                      <C>             <C>               <C>           <C>                <C>

                $*****-*****        $*****           *****%         $*****           $*****          $*****
----------------------------------------------------------------------------------------------------------------
                $*****-$*****       $*****           *****%         $*****           $*****          $*****
----------------------------------------------------------------------------------------------------------------
TOTALS                              $*****                          $*****           $*****          $*****
----------------------------------------------------------------------------------------------------------------
Base Salary                                                         $9,166.66                        $110,000.00
----------------------------------------------------------------------------------------------------------------
TOTALS                                                              $*****                           $*****
----------------------------------------------------------------------------------------------------------------
 Year End Bonus/Quick Zone        Quick Zone                                                         $*****
  based on sales from $*****-       Amt. At
       $*****                       *****%
                                    $*****
----------------------------------------------------------------------------------------------------------------
TOTAL                                                                                                $203,000.00
----------------------------------------------------------------------------------------------------------------
</TABLE>

---------------------
 *  In accordance with Rule 24b-2 under the Securities and Exchange Act of 1934,
    this confidential information has been omitted from this exhibit pursuant to
    a request for confidential treatment, and has been filed separately with the
    Securities and Exchange Commission.

                                  Page 3 of 4

<PAGE>

Table B (applicable retroactively for Bateman's compensation if the DermaLase is
not available for sale and shipment by August 1, 1999):
<TABLE>
<CAPTION>

-----------------------------------------------------------------------------------------------------------------
          Monthly Sales Amount   Monthly Sales   Commission Rate    Monthly      Annualized Sales   Annualized
                                    Amount                         Commission        Amount         Commission
-----------------------------------------------------------------------------------------------------------------
<S>     <C>                      <C>             <C>               <C>           <C>                <C>

                $*****-*****        $*****           *****%          $*****          $*****           $*****
-----------------------------------------------------------------------------------------------------------------
                $*****-$*****       $*****           *****%          $*****          $*****           $*****
-----------------------------------------------------------------------------------------------------------------
TOTALS                              $*****                           $*****          $*****           $*****
-----------------------------------------------------------------------------------------------------------------
Base Salary                                                          $9,166.66                        $110,000.00
-----------------------------------------------------------------------------------------------------------------
TOTALS                                                               $*****                           $*****
-----------------------------------------------------------------------------------------------------------------
 Year End Bonus/Quick Zone        Quick Zone                                                          $*****
  based on sales from $*****-       Amt. At
       $*****                       *****%
                                    $*****
-----------------------------------------------------------------------------------------------------------------
TOTAL                                                                                                 $200,000.00
-----------------------------------------------------------------------------------------------------------------
</TABLE>

---------------------
*    In accordance with Rule 24b-2 under the Securities and Exchange Act of
     1934, this confidential information has been omitted from this exhibit
     pursuant to a request for confidential treatment, and has been filed
     separately with the Securities and Exchange Commission.

Page 4 of 4

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00041-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00041-of-00352.parquet"}]]